======= SKA1 ======= == Gene Information == * **Official Symbol**: SKA1 * **Official Name**: spindle and kinetochore associated complex subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=220134|220134]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96BD8|Q96BD8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SKA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SKA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616673|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the SKA1 complex, a microtubule-binding subcomplex of the outer kinetochore that is essential for proper chromosome segregation (PubMed:17093495, PubMed:19289083, PubMed:23085020). Required for timely anaphase onset during mitosis, when chromosomes undergo bipolar attachment on spindle microtubules leading to silencing of the spindle checkpoint (PubMed:17093495). The SKA1 complex is a direct component of the kinetochore-microtubule interface and directly associates with microtubules as oligomeric assemblies (PubMed:19289083). The complex facilitates the processive movement of microspheres along a microtubule in a depolymerization-coupled manner (PubMed:19289083). Affinity for microtubules is synergistically enhanced in the presence of the ndc-80 complex and may allow the ndc-80 complex to track depolymerizing microtubules (PubMed:23085020). In the complex, it mediates the interaction with microtubules (PubMed:19289083, PubMed:23085020). {ECO:0000269|PubMed:17093495, ECO:0000269|PubMed:19289083, ECO:0000269|PubMed:23085020}. |DUF1395| |condensed chromosome outer kinetochore| |spindle microtubule| |mitotic spindle| |regulation of microtubule polymerization or depolymerization| |microtubule cytoskeleton| |regulation of microtubule cytoskeleton organization| |regulation of microtubule-based process| |microtubule binding| |chromosome segregation| |cell division| |regulation of cytoskeleton organization| |mitotic cell cycle| |regulation of organelle organization| |cell cycle| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-4.01| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-3.63| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-3.18| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.74| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-2.72| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.69| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.57| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.34| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.33| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-2.29| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-2.16| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.08| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.05| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.82| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-1.79| |[[:results:exp187|proTAME 5μM R04 exp187]]|-1.77| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.77| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.77| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.73| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.72| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.73| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|1.76| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.96| ^Gene^Correlation^ |[[:human genes:s:ska3|SKA3]]|0.562| |[[:human genes:k:kif18a|KIF18A]]|0.533| |[[:human genes:v:vbp1|VBP1]]|0.507| |[[:human genes:u:ube2c|UBE2C]]|0.498| |[[:human genes:s:stmn1|STMN1]]|0.485| |[[:human genes:s:ska2|SKA2]]|0.464| |[[:human genes:p:pfdn5|PFDN5]]|0.454| |[[:human genes:a:actr1a|ACTR1A]]|0.418| |[[:human genes:u:ube2s|UBE2S]]|0.418| |[[:human genes:a:arl2|ARL2]]|0.408| |[[:human genes:t:tubb4b|TUBB4B]]|0.405| |[[:human genes:a:anapc13|ANAPC13]]|0.405| Global Fraction of Cell Lines Where Essential: 30/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|1/28| |bone|0/26| |breast|1/33| |central nervous system|2/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|1/16| |kidney|0/21| |liver|0/20| |lung|4/75| |lymphocyte|0/16| |ovary|3/26| |pancreas|5/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|3/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2693 * **Expression level (log2 read counts)**: 5.42 {{:chemogenomics:nalm6 dist.png?nolink |}}